SCHEMBL14788390

SCHEMBL14788390

C#CC(=O)N(c1ccc(OC)cc1OC)C(C(=O)NCC(=O)O)c1cccs1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPX4 P36969 8/20 0.54
▸ LMNA P02545 3/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ YAP1 P46937 1/20 0.44
▸ PAX8 Q06710 1/20 0.44
▸ TEAD4 Q15561 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PIK3C3 Q8NEB9 1/20 0.44
▸ C5AR1 P21730 4/20 0.43
▸ POLB P06746 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29864762 0.89 GPX4 (0.49) GPX4LMNANPSR1NPC1RAB9A
SCHEMBL14788388 0.89 GPX4 (0.49) GPX4LMNANPSR1NPC1RAB9A
SCHEMBL27264728 0.89 GPX4 (0.70) GPX4LMNANPSR1NPC1RAB9A
SCHEMBL12639686 0.83 POLB (0.53) GPX4LMNANPSR1MAPTYAP1
SCHEMBL14788327 0.82 LMNA (0.47) GPX4LMNAMAPTSMN1; SMN2POLB
SCHEMBL12696355 0.81 C5AR1 (0.42) GPX4MAPTSMN1; SMN2C5AR1POLB
SCHEMBL14788496 0.80 GPX4 (0.49) GPX4LMNANPSR1NPC1RAB9A
SCHEMBL29172532 0.79 GPX4 (0.43) GPX4LMNANPSR1NPC1RAB9A
SCHEMBL14788385 0.78 CYP1A2 (0.49) GPX4LMNANPSR1MAPTYAP1
SCHEMBL14788457 0.76 C5AR1 (0.45) MAPTSMN1; SMN2C5AR1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130071328-A1 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130071328-A1 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon RELA, NFE2, NCOA1 GPX4 2413/4885LMNA 1318/4885NPSR1 3244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback